Clinical Trial Update: A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating perifosine for non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED